First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. (2023)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciad267
PubMed Identifier: 37315296
Publication URI: http://europepmc.org/abstract/MED/37315296
Type: Journal Article/Review
Volume: 77
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 6
ISSN: 1058-4838